Product NDC: | 51672-4138 |
Proprietary Name: | Granisetron Hydrochloride |
Non Proprietary Name: | Granisetron Hydrochloride |
Active Ingredient(s): | 1.12 mg/1 & nbsp; Granisetron Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4138 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090817 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100528 |
Package NDC: | 51672-4138-1 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (51672-4138-1) |
NDC Code | 51672-4138-1 |
Proprietary Name | Granisetron Hydrochloride |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (51672-4138-1) |
Product NDC | 51672-4138 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Granisetron Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100528 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | GRANISETRON HYDROCHLORIDE |
Strength Number | 1.12 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |